GI Issues & Cannabis
Track digestive symptoms against product chemistry. Build personal predictions for gastrointestinal comfort.
Gastrointestinal issues encompass a range of conditions including IBS, IBD (Crohn's and ulcerative colitis), and general digestive discomfort. The endocannabinoid system is believed to play a role in gut function, making cannabis a subject of research interest.
TOQidex helps you track 10 GI-specific symptoms against each product's measured chemistry, building a personal dataset over time.
10 Symptoms, Tied to Chemistry
Cannabis & GI Issues
Research into cannabis and gastrointestinal conditions is ongoing. Here is what some of the current literature explores:
- CB receptors in the gut: CB1 and CB2 receptors have been identified in the gastrointestinal tract. Researchers are studying their potential role in gut function. Clinical applications are not established.
- Anti-inflammatory research: Some cannabinoids, particularly CBG, are being studied for potential effects on gut inflammation. Evidence is primarily preclinical.
- Motility research: Some researchers are studying whether cannabinoids may affect gut motility. Results are mixed and individual responses vary.
Important: TOQidex does not make medical claims about cannabis and GI conditions. GI symptoms can indicate serious conditions requiring medical evaluation. The platform tracks your self-reported responses only. Always consult a gastroenterologist.
Being studied for potential gut-specific anti-inflammatory effects. Preclinical evidence.
Anti-inflammatory research ongoing. Effects on GI specifically not established.
Antiemetic properties studied. Complex relationship with gut motility.
CB2 agonist. Anti-inflammatory research ongoing.
Traditional use for digestive comfort. Clinical evidence limited.
Some users associate with general relaxation that may affect digestive comfort.
Frequently Asked Questions
Can cannabis help IBS or IBD?
Research is ongoing and results are mixed. TOQidex tracks your self-reported responses, not make treatment recommendations. Always work with your gastroenterologist.
From the Blog
Why Strain Names Are Unreliable (And What to Track Instead)
A study of 89,923 cannabis samples found that indica, sativa, and hybrid labels showed "no obvious segregation" against actual chemistry. Only 4 of 30 strains maintained consistent profiles across dispensaries. Here is what the research says.
Cannabinoids and Terpenes: The Chemistry That Drives Your Cannabis Experience
THC percentage is one data point. Your cannabis experience is shaped by at least 8 major cannabinoids and 9 dominant terpenes working together. Here is what the current research says about each compound.
Why TOQidex Tracks These 13 Medical Conditions
Over 6 million Americans hold medical cannabis cards. The conditions they manage are not random. Here is the data behind the 13 conditions TOQidex supports, why we chose them, and what the research says about patient-reported outcomes.
Other Conditions We Track
Start Tracking Your Experience
Join TOQidex to track how different products affect your symptoms.
Sign Up FreeTOQidex tracks user-reported symptom response. It does not diagnose, treat, cure, or prevent any condition. All outputs reflect probability based on your personal logged data.